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1. Introduction  
The prognosis of chronic liver disease depends on the progression of liver fibrosis. Liver 
biopsy is recommended as the gold standard method for determining fibrosis stage, 
prognosis and therapeutic indications in patients with chronic liver disease. However, liver 
biopsy is an invasive procedure associated with a risk of potentially serious complications. 
Approximately 1–3% of patients require hospitalization for complications, and a quarter of 
them report pain after percutaneous liver biopsy. The diagnostic accuracy of liver biopsy for 
assessing liver fibrosis is influenced by the quality of the biopsy samples. In addition, there 
are several absolute or relative contraindications to liver biopsy, including severe 
coagulopathy. A safe and non-invasive alternative to liver biopsy is therefore needed for 
assessing liver fibrosis in daily clinical practice. 
2. Principle of acoustic radiation force impulse  
Acoustic radiation force impulse (ARFI) imaging is a radiation force-based imaging method 
that is provided by conventional B-mode ultrasonography (Acuson S2000; SIEMENS 
Medical Solutions) (Fig. 1). ARFI imaging involves transmission of an initial ultrasonic pulse 
at diagnostic intensity levels to obtain a baseline signal for later comparison. A short-
duration (approximately 0.3 s), high-intensity acoustic ‘pushing pulse’ is then transmitted 
by the same transducer, followed by a series of diagnostic intensity pulses, which are used 
to track the displacement of the tissue caused by the pushing pulse (Nightingale et al., 2001, 
Palmeri et al., 2005, Dahl et al., 2007). The response of the tissue to the radiation force is 
observed using conventional B-mode imaging pulses, and it is possible to display the 
quantitative shear-wave velocity (Vs; m/s) of ARFI displacement. This velocity (m/s) is 
proportional to the square root of tissue elasticity. Because the velocity of the shear wave 
depends on tissue stiffness, it is possible to apply ARFI technology to elastography. This 
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technology was named “Virtual Touch Tissue Quantification” by SIEMENS. Previous 
reports have also referred to it as ARFI elastography or ARFI elastometry. In this chapter, 
we use the term ARFI elastography. 
3. Protocol of ARFI elastography 
ARFI imaging involves targeting an anatomic region to be examined for its elastic properties 
using a region-of-interest (ROI) cursor measuring 10×5 mm at the same time as or after 
performing real-time B-mode imaging (Fig. 2). This enables a comprehensive range of tissue 
strain analytic parameters to be assessed, allowing quantitative values of the mechanical 
stiffness (elasticity) properties of tissues to be measured. In general, the stiffer a region of 
tissue, the greater the shear-wave speed as it travels through this region. ARFI elastography is 
performed using a curved array at 4 MHz for B-mode imaging. The right lobe of the liver is 
examined through the intercostal space with the patient lying in the dorsal decubitus position, 
with their right arm maximally abducted. A measurement depth of 2–3 cm below the liver 
capsule is chosen to standardize the examination. No consensus has yet been reached 
regarding the ROI position and the approach point on the body surface, but our experience 
indicates that measurement at 2–3 cm depth from the right intercostals seems to produce 
stable results. According to a recent report, there was no significant difference in ARFI 
measurements between the intercostal and abdominal approaches; however, the intercostal 
approach had the highest success rates (Popescu et al., 2011). Although different values of 
ARFI measurements were reported for each depth under the liver capsule, the differences 
were not significant (Sporea et al., 2010). Boursier et al. reported that the reproducibility of 
measurements in the right lobe was high, but measurements in the left lobe included cases 
with outliers (Boursier et al., 2010). Further studies are needed to determine the depth of ROI 
for the appropriate stratification of liver fibrosis stages. The Acuson S2000 has a memory 
capability, and more than five successful acquisitions should thus be performed for each 
patient; the median or mean value can then be calculated to produce a reliable measurement. 
4. Reproducibility of ARFI elastography 
According to previous reports, ARFI elastography has high reproducibility. Boursier et al. 
reported that the interobserver reproducibility of ARFI was excellent (interclass correlation 
coefficient = 0.91) and no training effect was observed in terms of ARFI measurements 
(Boursier et al., 2010). Friedrich-Rust et al. found 87% agreement regarding ARFI 
elastography-derived stages between two examiners (Friedrich-Rust et al., 2009).  
5. ARFI elastography in normal healthy subjects 
Several studies have determined the normal range of ARFI measurements for healthy 
subjects. Popescu et al. reported a mean shear-wave velocity of 1.15 ± 0.21 m/s (Popescu et 
al., 2011). The study by Takahashi et al. included 25 healthy controls, and found a mean 
shear-wave value of 1.08 ± 0.13 m/s (Takahashi et al., 2010). The mean shear-wave velocity 
in the study by Horster et al., which included 68 healthy volunteers with a mean age of 28 
years, was 1.19 m/s (range, 0.77–1.63 m/s) (Horster et al., 2010), while Goertz et al. obtained 
a mean value of 1.09 m/s (range, 0.79–1.32 m/s) in 20 healthy subjects. Kim et al. included 
133 subjects with normal livers in their series and derived a mean value of 1.08 ± 0.15 m/s 
(Goertz et al., 2010, Kim et al., 2010). No correlations between ARFI values and age, gender 
or body mass index (BMI) have been identified. 
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6. Diagnostic accuracy for liver fibrosis 
Ultrasonography-based evaluation offers several advantages, including ready availability, 
real-time examination, relatively low cost and lack of ionizing radiation. Recent studies have 
indicated the clinical feasibility of ARFI elastography for assessing liver fibrosis (Table 1). 
The results demonstrated that shear-wave velocity measured by ARFI elastography offers a 
reliable and non-invasive method for estimating liver fibrosis in chronic liver diseases. In 
particular, liver stiffness assessed by shear-wave velocity was significantly correlated with 
liver fibrosis according to the pathological scoring system. Furthermore, the staging of liver 
fibrosis in chronic liver diseases could be accurately classified based on shear-wave velocity. 
Friedrich-Rust et al. reported that the area under the receiver operating characteristic curve 
for the accuracy of ARFI elastography was 0.91 for the diagnosis of both moderate fibrosis 
(F≥2) and cirrhosis, respectively. According to their report, the cut-off value for liver 
cirrhosis was 1.75 m/s in all subjects, and 1.75 m/s in subjects with hepatitis C virus (HCV) 
infection (Friedrich-Rust et al., 2009). Other reports have identified variable cut-off values 
for cirrhosis, ranging from 1.6–1.95 m/s (Table 1). In the studies by Takahashi et al. and 
Sporea et al., which included 47 (85%) and 54 (76%) HCV-positive subjects, respectively, the 
cut-off value for cirrhosis was 1.8 m/s (Takahashi et al., 2010, Sporea et al., 2010). The study 
by Yoneda et al. included subjects with non-alcoholic fatty liver disease (NAFLD), and 
found a cut-off value for cirrhosis of 1.9 m/s, which was higher than in other studies 
(Yoneda et al., 2010). It is possible that differences in background chronic liver diseases 
might account for the variations in cut-off values. In addition, different distributions of 
fibrosis stages among subjects in different studies may affect the results of ROC analysis, 
and direct comparison of cut-off values among studies should therefore be avoided. The 
Obuchowski measure, which allows for differential penalization of more serious 
misdiagnoses, was recently reported (Obuchowski et al., 2005). This method allows the 
diagnostic accuracy of ARFI elastography among studies with different distributions of 
fibrosis stages to be compared (Lambert et al., 2008). However, because the Obuchowski 
measure is statistically technical, analysis with commercially-based medical statistical 
software might be difficult. Further studies on the correlations between different liver 
disease etiologies and the results of ARFI elastography are needed, as are standardized 
measurement protocols and statistical methods. Nonetheless, ARFI elastography appears to 
offer good diagnostic accuracy for staging liver fibrosis.  
               
  AUROC 
Cut-off for 
cirrhosis 
Author Subjects FS 0–1vs FS 2–4 FS 0–2 vs. FS 3–4 FS 0–3 vs. FS 4 (m/s) 
Friedrich- 
Rust et al. 
HCV, HBV 0.84 0.91 0.91 1.75 
Takahashi et al. HCV, HBV, NASH 0.94 0.94 0.96 1.8 
Yoneda et al. NAFLD - 0.97 0.98 1.9 
Sporea et al. HCV, HBV 0.65  0.87 1.8 
Goertz et al. HCV, HBV 0.85 0.92 0.87 - 
Fierbinteanu-
Braticevici et al. 
HCV 0.92 0.99 0.99 1.95 
Rifai et al. HCV, HBV, NAFLD - - 0.82 1.6 






AUROC, area under the receiver operating characteristic curve; FS, fibrosis stage; HCV, 
hepatitis C virus; HBV, hepatitis B virus; NAFLD, non-alcoholic fatty liver disease. Fibrosis 
stage was assessed using the Metavir scoring system, except in the case of Yoneda et al., 
who used the method of Brunt.  
7. Factors influencing ARFI elastography measurements 
The degree of liver fibrosis is the most significant factor determining shear-wave velocity. 
However, several other factors can affect shear-wave velocity. Rifai et al. reported that 
shear-wave velocity was faster in patients with significant liver inflammation compared 
with those with no significant inflammation (Rifai et al., 2011). They suggested that liver and 
spleen sizes were positively correlated with the results of ARFI elastography measurements. 
Takahashi et al. reported that serum aspartate aminotransferase and alanine 
aminotransferase levels as well as pathological liver inflammation were positively correlated 
with ARFI elastography measurements (Takahashi et al., 2010). These results suggest that 
pathological and serological liver inflammation might affect shear-wave velocity. However, 
it should be noted that significant proportions of patients in those studies had viral 
hepatitis, and the severity of pathological fibrosis has been shown to correlate with 
pathological inflammation in viral hepatitis. Further studies including larger sample sizes 
are needed to evaluate the impact of inflammation on ARFI elastography measurements in 
patients with the same severities of fibrosis stage.  
Pathological liver steatosis is a significant factor affecting ARFI elastography measurements 
in NAFLD. Yoneda et al. suggested that shear-wave velocity in NAFLD with no fibrosis was 
slower than in healthy controls. Additionally, NAFLD with mild liver fibrosis was 
associated with almost normal shear-wave velocities (Yoneda et al., 2010, Palmeri et al., 
2011). They suggested that steatosis might make the liver softer because of fat deposition in 
the liver parenchyma. Palmeri et al. showed that hepatocyte ballooning and inflammation in 
NAFLD had no significant effects on shear-wave velocity (Palmeri et al., 2011).  
8. Comparison with other non-invasive methods 
Several scoring systems or indexes based on serum biochemical markers have been 
proposed for the non-invasive prediction of liver fibrosis in chronic liver disease. 
Additionally, transient elastography (FibroScan) has recently been developed as a non-
invasive method for the evaluation of liver fibrosis, by assessing liver stiffness based on a 
mechanical wave generated by vibration. The diagnostic accuracy of ARFI has been shown 
to be comparable with that of previously reported non-invasive scoring systems such as 
AST to Platelet Ratio Index (APRI), Fib-4 and Forn’s index (Takahashi et al, 2010). Several 
studies have reported both ARFI and FibroScan measurements. The results of ARFI 
elastography were highly correlated with those of FibroScan measurements, though the 
success rate of ARFI measurements was higher than that for FibroScan. To the best of our 
knowledge, few reports have compared the diagnostic accuracies of ARFI and FibroScan, 
based on the gold standard of liver biopsy. Sporea et al. suggested that the accuracy of ARFI 
elastography was acceptable but lower than that of FibroScan (Sporea et al., 2010), while 
Friedrich-Rust et al. and Rifai et al. found no significant differences in diagnostic accuracy 
between the two techniques (Table 2) (Friedrich-Rust et al., 2009, Rifai et al., 2011). It thus 
remains unclear which form of elastography is more reliable; however, a prospective 
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multicenter study and meta-analysis are currently underway. Nonetheless, ARFI 
elastography appears to be useful because of its fewer limitations and the integration of 
elastography and conventional B-mode ultrasonography.    
 
  FS 0–1 vs. FS 2–4 FS 0–3 vs. FS 4 
Author Subjects ARFI FibroScan ARFI FibroScan 
Friedrich-Rust et al. HCV, HBV 0.82 0.84 0.91 0.91 
Sporea et al. HCV, HBV 0.65 0.73 0.87 0.94 
Rifai et al. HCV, HBV, NAFLD - - 0.82 0.84 
Table 2. Diagnostic accuracy of ARFI and FibroScan for liver fibrosis 
AUROC, area under the receiver operating characteristic curve; FS, fibrosis stage; HCV, 
hepatitis C virus; HBV, hepatitis B virus; NAFLD, non-alcoholic fatty liver disease. Fibrosis 
stage was assessed using the Metavir scoring system, except in the case of Yoneda et al., 
who used the method of Brunt.        
9. Limitations and possible contraindications of ARFI elastography  
No significant limitations or contraindication of ARFI elastography for liver assessment 
have been reported to date. However, the Japan Society of Ultrasonics in Medicine 
recommends that ARFI elastography should be avoided after contrast-enhanced 
ultrasonography with some kinds of contrast agents, because of the risk of cavitation. The 
limitations of transient elastography, such as narrow intercostal spaces, ascites and obesity, 
do not appear to apply to the use of ARFI elastography, according to our data and the 
results of previous reports. However, the success rate of ARFI measurements in subjects 
with a BMI >40 kg/m2 was reportedly only 58% (Palmeri et al., 2011). Further studies are 
needed to allow more precise evaluation of the limitations of ARFI elastography.  
 
 






Acoustic radiation force impulse (ARFI) is a radiation force-based impulse that is provided 
by conventional B-mode ultrasonography, using an Acuson S2000. The ARFI method can be 




Fig. 2. Measurement window for ARFI elastography 
10. Conclusion  
In conclusion, the novel, non-invasive ultrasonic ARFI elastography technique, coupled 
with conventional ultrasonography, could offer a reliable method for the assessment of liver 
fibrosis in patients with chronic liver diseases. ARFI elastography could be useful for real-
time evaluation of liver fibrosis as an alternative to liver biopsy. 
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